Previous Close | 2.18 |
1-Year Change | -85.22% |
6-Months Change | -64.09% |
3-Months Change | -56.75% |
Moving Avg (50d) | 3.7276 |
Moving Avg (200d) | 5.1258 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 340.4M |
Beta (3-Years) | 0.55 |
Revenue Growth (ttm) | 2.82% |
Net Profit Margin (ttm) | -220.24% |
Return On Assets (ttm) | -181.71% |
EPS (ttm) | -6.23 |
PE Ratio (ttm) | -0.35 |
Dividend Yield | % |
Asset Description: | Ironwood Pharmaceuticals, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-02-03 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
2.224 | 2.289 | 2.333 | 2.398 | 2.507 | 2.616 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.